These potent anti-tumor effects are concurrent with simultaneous reduction in expression of multiple putative oncogenes downstream of TGFBR2, essentially mimicking a combinatorial treatment strategy (Fig. 6), highlighting the translational potential of this approach.45 Here, TGFBR2 is linked to neoplasm.